Psychemedics

Psychemedics EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Psychemedics (PMDI) as of Nov 2, 2026 is -22.76 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was -23.70 % — a change of -3.97% (higher).

EBIT/Assets

-22.76 %

YoY

-3.97%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Psychemedics is 2024 -22.76 % . Operating Income to Assets Ratio (EBIT/Assets) of Psychemedics was 2023 -23.70 % . It decreases by -3.97% higher compared to the previous year.

The Psychemedics EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2017
30.78 USD
Jan 1, 2018
30.48 USD
Jan 1, 2019
10.90 USD
Jan 1, 2020
-25.27 USD
Jan 1, 2021
0.97 USD
Jan 1, 2022
-5.78 USD
Jan 1, 2023
-23.70 USD
Jan 1, 2024
-22.76 USD
The Psychemedics EBIT/Assets history
YEAREBIT/AssetsYoY
-22.76 %-3.97%
-23.70 %+309.89%
-5.78 %-696.19%
0.97 %-103.84%
-25.27 %-331.91%
10.90 %-64.24%
30.48 %-0.99%
30.78 %-23.79%
40.39 %+505.60%
6.67 %-65.76%
19.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp provides drug testing services analyzing hair samples for drug presence, offering historical usage patterns and approximate drug intake levels. The company charges customers a per-unit fee for each tested sample, including training for sample collection and storage of positive results. Their primary service targets clients needing drug testing solutions, particularly in sectors requiring regular monitoring of substance use. The firm's technology focuses on hair analysis to deliver detailed insights into drug consumption over time. Psychemedics Corp's revenue model is based on per-unit testing fees, with services including sample collection training and storage of positive samples. Customers pay for each sample tested, leveraging the company's hair analysis technology to monitor drug use patterns. The business operates within the drug testing services segment, serving clients who require reliable and historical data on substance abuse. The company's drug testing services are designed for customers seeking detailed historical data on drug use, with results indicating both the amount ingested and usage patterns over time. Psychemedics Corp generates income through fixed fees per sample tested, covering the full service including sample collection training and positive sample storage. Their focus remains on delivering accurate, long-term drug usage insights through hair analysis. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Operating Income to Assets Ratio (EBIT/Assets) of Psychemedics is -22.76 % in 2024.

Operating Income to Assets Ratio (EBIT/Assets) of Psychemedics changed from -23.70 % to -22.76 %, representing a -3.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Psychemedics since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Psychemedics with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Psychemedics

All Key Metrics — Psychemedics